Ackman looking for next target, as Allergan looks like a bust

[Anonymous]

from Barron's...

Citing unnamed sources, the WSJ reports that Ackman could be setting up Zoetis as a “a fallback plan” for Valeant Pharmaceuticals (VRX) if it fails to buy Allergan (AGN)

Ackman informed Zoetis of the stake in a phone call, the company said in a statement, without providing further details. Another fund, Sachem Head Capital Management LP, raised its stake to about 1.6 percent in partnership with Pershing Square to increase shareholder returns at the company, according to a Pershing Square statement yesterday.

 

[Anonymous]

from Barron's...

Citing unnamed sources, the WSJ reports that Ackman could be setting up Zoetis as a “a fallback plan” for Valeant Pharmaceuticals (VRX) if it fails to buy Allergan (AGN)

Ackman informed Zoetis of the stake in a phone call, the company said in a statement, without providing further details. Another fund, Sachem Head Capital Management LP, raised its stake to about 1.6 percent in partnership with Pershing Square to increase shareholder returns at the company, according to a Pershing Square statement yesterday.

...and your point is? either Ackman or Activis! Does it really matter when it comes to losing your independence and value?

 

[Anonymous]

Looks like we got a white knight! Screw you Mikey P!

 

[Anonymous]

Looks like we got a white knight! Screw you Mikey P!

Can't wait till the AGN stock gets delisted...

 

[Anonymous]

End of an Era!

 

[Anonymous]

...and your point is? either Ackman or Activis! Does it really matter when it comes to losing your independence and value?

Anyone who doesn't see that Valeant is a company so bad
- that its own consultants call it "a house of cards"
- its accounting practices are described as murky at best
- and its only hope is in destroying Alergan's R&D and using the money it saves to service its huge debt load over the short-term...

Well, it matters! Getting bought sucks, but getting bought by Valeant vs anyone else (short of Enron or Tyco)... there's a difference.

 

[Anonymous]

Anyone who doesn't see that Valeant is a company so bad
- that its own consultants call it "a house of cards"
- its accounting practices are described as murky at best
- and its only hope is in destroying Alergan's R&D and using the money it saves to service its huge debt load over the short-term...

Well, it matters! Getting bought sucks, but getting bought by Valeant vs anyone else (short of Enron or Tyco)... there's a difference.

...speaking from a sales rep perspective, it doesn't matter who does the buying! Our jobs and work/life balance will never be the same...actavis or valeant, does not matter! My job is still in question and my ability to sell in a comfortable environment is no more

 

[Anonymous]

It's amazing to see how this has played, our mgt dressed up valeant to be the worse possible takeover ever, and now almost saying nothing about actavis, who will do more or less the same thing, worse I'd say as they will be spending more money to buy us.

Sher ive seen it called a merger lol.

 

[Anonymous]

It's amazing to see how this has played, our mgt dressed up valeant to be the worse possible takeover ever, and now almost saying nothing about actavis, who will do more or less the same thing, worse I'd say as they will be spending more money to buy us.

Sher ive seen it called a merger lol.

The "white knight" Actavis swoops in to save Allergan from the "vile" Valeant/Ackman.

The higher price is great for shareholders, but it will come at the price of deeper cuts.

 

[Anonymous]

Troolls and PR tools all of ya! Activis is way better and offering more. And stable.

 

[Anonymous]

Troolls and PR tools all of ya! Activis is way better and offering more. And stable.

Yeah, activas is way better! Just asked Warner Chillcott

 

[Anonymous]

Valeant debt/assets 60%

Acatvis debt/assets 29%

I'll take Actavis and a potential future versus Valeant's certain faliure.

 

[Anonymous]

Valeant and Pershing Square have now sold all their 2.2 million Allergan shares held in PS-1. Take the money and run...

 

[Anonymous]

It's amazing to see how this has played, our mgt dressed up valeant to be the worse possible takeover ever, and now almost saying nothing about actavis, who will do more or less the same thing, worse I'd say as they will be spending more money to buy us.

Sher ive seen it called a merger lol.[/QUOTE




Back to business as usual - we will here this a lot!

 

[Anonymous]

Bill Ackman is nothing short of scum. He is a greedy putz who cares only about his bottom line. Insider trading? Most definitely! He should be in jail.

 

[Anonymous]

Same with DP- total dink

 

[Anonymous]

End of an Era!

Allergan's "era" was over long ago.

 

[Anonymous]

Valeant and Pershing Square have now sold all their 2.2 million Allergan shares held in PS-1. Take the money and run...

Look who the smartest ones were! Made some serious cash on the back of Pyott.

 

[Anonymous]

Bill Ackman is nothing short of scum. He is a greedy putz who cares only about his bottom line. Insider trading? Most definitely! He should be in jail.

No different that the Allergan execs.

 

[Anonymous]

Its only a bust for Valeant. Ackman made out like a bandit. I actually think that he played Valeant. Unfortunately, at Allergan's expense.